The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.
Study links glucose time series complexity to diabetes progression
Weiping Jia et al., at Shanghai Jiao Tong University School of Medicine Affiliated Sixth People’s Hospital, China, conducted a study to explore the relationship between